Sitagliptin, sitagliptin and metformin, or sitagliptin and amitriptyline attenuate streptozotocin-nicotinamide induced diabetic neuropathy in rats

@inproceedings{Sharma2012SitagliptinSA,
  title={Sitagliptin, sitagliptin and metformin, or sitagliptin and amitriptyline attenuate streptozotocin-nicotinamide induced diabetic neuropathy in rats},
  author={Ashish Kumar Sharma and Akash M Sharma and R. Vasantha Kumari and Kunal Kishore and Divya Sharma and Bharthu Parthsarthi Srinivasan and Ashok Sharma and Santosh kumar Singh and Samir Gaur and Vijay Singh Jatav and Prashant Sharma and Varnika Srivastava and Sneha Joshi and Megha Joshi and Prashant Kumar Dhakad and Davender Singh Kanawat and Akanksha Mishra and Anil Ratan Sharma and Dharmendra Singh and Ravinder Pal Singh and Himmat Singh Chawda and Rambir Singh and Sachin Kumar Raikwar and Muneem Kumar Kurmi and Pankaj Khatri and Ashutosh Agarwal and Arshee Munajjam},
  booktitle={Journal of biomedical research},
  year={2012}
}
Diabetic neuropathies are a family of nerve disorders caused by diabetes. Symptoms of the disease include nerve palsy, mononeuropathy, mononeuropathy multiplex, diabetic amyotrophy, painful polyneuropathy, autonomic neuropathy, and thoracoabdominal neuropathy. In this study, type 2 diabetes in rats was induced with nicotinamide-streptozotocin. Drug treatment was initiated on the d 15, with the combination regimen of metformin, pioglitazone and glimipiride or metformin and sitagliptin or… CONTINUE READING